BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6434703)

  • 1. Discrimination between nonmalignant and malignant cells by combinations of IFN-gamma and IFN-alpha/beta.
    Fleischmann WR; Newton RC; Fleischmann CM; Colburn NH; Brysk MM
    J Biol Response Mod; 1984 Aug; 3(4):397-405. PubMed ID: 6434703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
    Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
    Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.
    Fleischmann WR
    Cancer Res; 1982 Mar; 42(3):869-75. PubMed ID: 6174218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antineoplastic effect of beta-IFN and gamma-IFN on malignant gliomas].
    Nakamura O; Nomura K; Maruo K; Ueyama Y; Matsutani M; Takakura K
    No To Shinkei; 1987 Jul; 39(7):627-32. PubMed ID: 3118910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
    Hubbell HR; Liu RS; Maxwell BL
    Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of cultured human melanoma cells by immune interferon and leukocytes.
    Tyring SK; Klimpel G; Brysk M; Gupta V; Stanton GJ; Fleischmann WR; Baron S
    J Natl Cancer Inst; 1984 Nov; 73(5):1067-73. PubMed ID: 6436563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of type I IFNs on the growth of WC1- CD8+ gamma delta T cells and WC1+ CD8- gamma delta T cells in vitro.
    Tuo W; Bazer FW; Davis WC; Zhu D; Brown WC
    J Immunol; 1999 Jan; 162(1):245-53. PubMed ID: 9886392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferon.
    Hubbell HR; Craft JA; Leibowitz PJ; Gillespie DH
    J Biol Response Mod; 1987 Apr; 6(2):141-53. PubMed ID: 3108460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hyperthermia on the in vitro antiproliferative activities of HuIFN-alpha, HuIFN-beta, and rHuIFN-gamma employed separately and in combination.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(3):145-54. PubMed ID: 3151143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic study on human interferon-beta: Part II. Anticellular effect].
    Kanamori T; Tobita M; Horisawa Y; Nobuhara M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2105-10. PubMed ID: 3717958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual and combined tumoricidal effects of dexamethasone and interferons on human leukocyte cell lines.
    Pan LY; Guyre PM
    Cancer Res; 1988 Feb; 48(3):567-71. PubMed ID: 3121176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large component of the antiviral activity of mouse interferon-gamma may be due to its induction of interferon-alpha.
    Hughes TK; Baron S
    J Biol Regul Homeost Agents; 1987; 1(1):29-32. PubMed ID: 3142215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
    Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
    J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.